ArticleBMC bioinformatics2026
mFLIP: metabolic flux interval prediction.
Article in BMC bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundUnderstanding cellular metabolism often involves an accurate estimation of metabolic fluxes-the rates at which metabolites are converted in biochemical pathways. Flux Variability Analysis (FVA) is the gold standard for computing reaction flux intervals. However, its reliance on linear programming makes it computationally intensive, often requiring hours or days for large cohorts on complex genome-scale metabolic network models.
methodsTo address this limitation, we propose mFLIP, a machine learning-based framework for predicting flux intervals across metabolic pathways. The models were trained using large-scale metabolomics datasets comprising over 22,000 samples obtained from Metabolomics Workbench and MetaboLights. Multiple machine learning and deep learning approaches, including Random Forest, XGBoost, CNN, GNN, VAE, and FT-Transformer, were evaluated. Model performance was independently validated across six independent cancer datasets (Breast, Colon, Pancreatic, Prostate, and two stages of Clear Cell Renal Carcinoma).
resultsThe proposed approach significantly reduces computation time from minutes to under a second during inference. Among the evaluated models, Random Forest and XGBoost achieved the best overall performance, with the lowest regression errors and highest classification scores. Deep learning models, particularly CNN and FT-Transformer, also demonstrated competitive results. Overall, all proposed methods outperformed the state-of-the-art baseline in terms of both accuracy and computational efficiency.
conclusionsmFLIP provides a fast and accurate alternative to traditional FVA-based approaches for metabolic flux interval estimation. By leveraging supervised learning on FVA-derived data, it enables scalable analysis of large cohorts while maintaining high predictive performance, making it a practical tool for large-scale metabolic studies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.